Skip to main content
Top
Published in: Diabetologia 9/2012

01-09-2012 | Article

Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice

Authors: M. González-Granillo, K. R. Steffensen, O. Granados, N. Torres, M. Korach-André, V. Ortíz, C. Aguilar-Salinas, T. Jakobsson, A. Díaz-Villaseñor, A. Loza-Valdes, R. Hernandez-Pando, J.-Å. Gustafsson, A. R. Tovar

Published in: Diabetologia | Issue 9/2012

Login to get access

Abstract

Aims/hypothesis

Liver X receptor (LXR)α regulates the genes involved in cholesterol, fatty acid and glucose metabolism. Soy protein (SP) consumption reduces the hepatic accumulation of cholesterol and triacylglycerol, and improves insulin sensitivity. However, it is not known whether these effects are mediated via LXRα. We therefore investigated whether the consumption of SP regulates metabolic changes in cholesterol metabolism and insulin sensitivity via LXRα.

Methods

Wild-type (WT) and Lxrα −/− (Lxrα, also known as Nr1h3) mice were fed an SP diet with or without cholesterol for 28 days. The expression of LXRα target genes was measured in liver and intestine, as were hepatic lipid content and faecal bile acid concentration. Oral glucose and insulin tolerance tests were also performed. Hepatocytes were used to study the effect of isoflavones on LXR activity.

Results

The livers of WT and Lxrα −/− mice fed an SP high-cholesterol diet showed less steatosis than those fed casein. The SP diet increased the expression of the ATP-binding cassette (ABC) sub-family genes Abca1, Abcg5 and Abcg8 in the liver and intestine, as well as increasing total faecal bile acid excretion and insulin sensitivity in WT mice compared with mice fed a casein diet. However, these effects of SP were not observed in Lxrα −/− mice. The SP isoflavone, genistein, repressed the activation of LXRα target genes by T0901317, whereas it stimulated the activation of LXRβ target genes. The AMP-activated protein kinase inhibitor, compound C, had the opposite effects to those of genistein.

Conclusions/interpretation

Our results suggest that SP isoflavones stimulate the phosphorylation of LXRα or LXRβ, resulting in different biological effects for each LXR isoform.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wiklund P, Toss F, Weinehall L et al (2008) Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 93:4360–4366PubMedCrossRef Wiklund P, Toss F, Weinehall L et al (2008) Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 93:4360–4366PubMedCrossRef
2.
go back to reference Houston DK, Nicklas BJ, Zizza CA (2009) Weighty concerns: the growing prevalence of obesity among older adults. J Am Diet Assoc 109:1886–1895PubMedCrossRef Houston DK, Nicklas BJ, Zizza CA (2009) Weighty concerns: the growing prevalence of obesity among older adults. J Am Diet Assoc 109:1886–1895PubMedCrossRef
3.
4.
5.
go back to reference Doria A, Patti ME, Kahn CR (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab 8:186–200PubMedCrossRef Doria A, Patti ME, Kahn CR (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab 8:186–200PubMedCrossRef
6.
go back to reference Grundy SM, Cleeman JI, Merz CN et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239PubMedCrossRef Grundy SM, Cleeman JI, Merz CN et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239PubMedCrossRef
7.
go back to reference Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53:577–584PubMedCrossRef Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53:577–584PubMedCrossRef
8.
go back to reference Olaiz-Fernandez G, Rivera-Dommarco J, Shamah-Levy T et al (2006) Encuesta Nacional de Salud y Nutricion. Instituo Nacional de Salud Publica, Cuernavaca Olaiz-Fernandez G, Rivera-Dommarco J, Shamah-Levy T et al (2006) Encuesta Nacional de Salud y Nutricion. Instituo Nacional de Salud Publica, Cuernavaca
9.
go back to reference Ginsberg HN (2006) REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 91:383–392PubMedCrossRef Ginsberg HN (2006) REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 91:383–392PubMedCrossRef
10.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
11.
go back to reference Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276–282PubMedCrossRef Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276–282PubMedCrossRef
12.
go back to reference Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408PubMed Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408PubMed
13.
go back to reference Tovar AR, Murguia F, Cruz C et al (2002) A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132:2562–2569PubMed Tovar AR, Murguia F, Cruz C et al (2002) A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132:2562–2569PubMed
14.
go back to reference Tovar AR, Torre-Villalvazo I, Ochoa M et al (2005) Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46:1823–1832PubMedCrossRef Tovar AR, Torre-Villalvazo I, Ochoa M et al (2005) Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46:1823–1832PubMedCrossRef
15.
go back to reference Torre-Villalvazo I, Tovar AR, Ramos-Barragan VE, Cerbon-Cervantes MA, Torres N (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138:462–468PubMed Torre-Villalvazo I, Tovar AR, Ramos-Barragan VE, Cerbon-Cervantes MA, Torres N (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138:462–468PubMed
16.
go back to reference Noriega-Lopez L, Tovar AR, Gonzalez-Granillo M et al (2007) Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 282:20657–20666PubMedCrossRef Noriega-Lopez L, Tovar AR, Gonzalez-Granillo M et al (2007) Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 282:20657–20666PubMedCrossRef
17.
go back to reference Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125:606S–611SPubMed Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125:606S–611SPubMed
18.
go back to reference Peet DJ, Turley SD, Ma W et al (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693–704PubMedCrossRef Peet DJ, Turley SD, Ma W et al (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693–704PubMedCrossRef
19.
go back to reference Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793–18800PubMedCrossRef Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793–18800PubMedCrossRef
20.
go back to reference Schroepfer GJ Jr (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80:361–554PubMed Schroepfer GJ Jr (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80:361–554PubMed
21.
go back to reference Gabbi C, Warner M, Gustafsson JA (2009) Minireview: liver X receptor beta: emerging roles in physiology and diseases. Mol Endocrinol 23:129–136PubMedCrossRef Gabbi C, Warner M, Gustafsson JA (2009) Minireview: liver X receptor beta: emerging roles in physiology and diseases. Mol Endocrinol 23:129–136PubMedCrossRef
22.
go back to reference Lewis GF, Rader DJ (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96:1221–1232PubMedCrossRef Lewis GF, Rader DJ (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96:1221–1232PubMedCrossRef
23.
go back to reference Repa JJ, Mangelsdorf DJ (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16:459–481PubMedCrossRef Repa JJ, Mangelsdorf DJ (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16:459–481PubMedCrossRef
24.
go back to reference Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614PubMedCrossRef Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614PubMedCrossRef
25.
go back to reference Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG (2009) Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology 49:1913–1925PubMedCrossRef Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG (2009) Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology 49:1913–1925PubMedCrossRef
26.
go back to reference Torra IP, Ismaili N, Feig JE et al (2008) Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol Cell Biol 28:2626–2636PubMedCrossRef Torra IP, Ismaili N, Feig JE et al (2008) Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol Cell Biol 28:2626–2636PubMedCrossRef
27.
go back to reference Shen P, Liu MH, Ng TY, Chan YH, Yong EL (2006) Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 136:899–905PubMed Shen P, Liu MH, Ng TY, Chan YH, Yong EL (2006) Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 136:899–905PubMed
28.
go back to reference Kuiper GG, Lemmen JG, Carlsson B et al (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252–4263PubMedCrossRef Kuiper GG, Lemmen JG, Carlsson B et al (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252–4263PubMedCrossRef
29.
go back to reference Shay NF, Banz WJ (2005) Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu Rev Nutr 25:297–315PubMedCrossRef Shay NF, Banz WJ (2005) Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu Rev Nutr 25:297–315PubMedCrossRef
30.
go back to reference Alberti S, Schuster G, Parini P et al (2001) Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565–573PubMedCrossRef Alberti S, Schuster G, Parini P et al (2001) Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565–573PubMedCrossRef
31.
go back to reference Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed
32.
go back to reference Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef
33.
go back to reference Barakat HA, Dohm GL, Loesche P, Tapscott EB, Smith C (1976) Lipid content and fatty acid composition of heart and muscle of the BIO 82.62 cardiomyopathic hamster. Lipids 11:747–751PubMedCrossRef Barakat HA, Dohm GL, Loesche P, Tapscott EB, Smith C (1976) Lipid content and fatty acid composition of heart and muscle of the BIO 82.62 cardiomyopathic hamster. Lipids 11:747–751PubMedCrossRef
34.
go back to reference Keller S, Jahreis G (2004) Determination of underivatised sterols and bile acid trimethyl silyl ether methyl esters by gas chromatography-mass spectrometry-single ion monitoring in faeces. J Chromatogr B Analyt Technol Biomed Life Sci 813:199–207PubMedCrossRef Keller S, Jahreis G (2004) Determination of underivatised sterols and bile acid trimethyl silyl ether methyl esters by gas chromatography-mass spectrometry-single ion monitoring in faeces. J Chromatogr B Analyt Technol Biomed Life Sci 813:199–207PubMedCrossRef
35.
go back to reference Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506–520PubMedCrossRef Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506–520PubMedCrossRef
36.
go back to reference Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA (2010) Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol Endocrinol Metab 298:E167–E178PubMedCrossRef Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA (2010) Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol Endocrinol Metab 298:E167–E178PubMedCrossRef
37.
go back to reference Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277PubMedCrossRef Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277PubMedCrossRef
38.
go back to reference Ronis MJ, Chen Y, Badeaux J, Badger TM (2009) Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr 139:1431–1438PubMedCrossRef Ronis MJ, Chen Y, Badeaux J, Badger TM (2009) Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr 139:1431–1438PubMedCrossRef
39.
go back to reference Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF (2005) Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 16:321–330PubMedCrossRef Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF (2005) Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 16:321–330PubMedCrossRef
40.
go back to reference Hwang JT, Park IJ, Shin JI et al (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694–699PubMedCrossRef Hwang JT, Park IJ, Shin JI et al (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694–699PubMedCrossRef
41.
go back to reference Palacios-Gonzalez B, Torres N, Tovar AR (2011) Genistein stimulates AMPK-phosphorylation and expression of genes involved in fatty acid oxidation in skeletal muscle. FASEB J 25:772.777 Palacios-Gonzalez B, Torres N, Tovar AR (2011) Genistein stimulates AMPK-phosphorylation and expression of genes involved in fatty acid oxidation in skeletal muscle. FASEB J 25:772.777
42.
go back to reference Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435PubMedCrossRef Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435PubMedCrossRef
43.
go back to reference Hessvik NP, Boekschoten MV, Baltzersen MA et al (2010) LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. Am J Physiol Endocrinol Metab 298:E602–E613PubMedCrossRef Hessvik NP, Boekschoten MV, Baltzersen MA et al (2010) LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. Am J Physiol Endocrinol Metab 298:E602–E613PubMedCrossRef
44.
go back to reference Anderson JW, Bush HM (2011) Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 30:79–91PubMed Anderson JW, Bush HM (2011) Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 30:79–91PubMed
45.
go back to reference Jenkins DJ, Mirrahimi A, Srichaikul K et al (2010) Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140:2302S–2311SPubMedCrossRef Jenkins DJ, Mirrahimi A, Srichaikul K et al (2010) Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140:2302S–2311SPubMedCrossRef
Metadata
Title
Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice
Authors
M. González-Granillo
K. R. Steffensen
O. Granados
N. Torres
M. Korach-André
V. Ortíz
C. Aguilar-Salinas
T. Jakobsson
A. Díaz-Villaseñor
A. Loza-Valdes
R. Hernandez-Pando
J.-Å. Gustafsson
A. R. Tovar
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2599-9

Other articles of this Issue 9/2012

Diabetologia 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.